| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |